Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
national top stories
boston
clinical trials
eli lilly
roche
san francisco blog main
san francisco top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
avapritinib
axial spondyloarthritis
bausch health
biogen
biopharma
blueprint medicines
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
crispr
cstone pharmaceuticals
detroit blog main
detroit top stories
What
approval
3
×
drug
fda
roche
betting
billion
bio
biogen’s
biopharma
biopharmaceutical
blueprint
cancer
candidate
companies
convo
currently
deal
duchenne
earlier
failures
gene
historic
littered
marketing
medicine
medicines
muscle
nash
new
news
pact
price
puts
recently
regulatory
remains
ret
review
rna
road
Language
unset
Current search:
approval
×
biotech
×
deals
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
